← back to search

Mark Schattner

Memorial Sloan Kettering Cancer Center · US
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Gastric Cancer Management and Outcomes, Esophageal Cancer Research and Treatment, Esophageal and GI Pathology, and Pancreatic and Hepatic Oncology Research.
h-index
43
citations
6,235
works
270
NIH funding
primary concept
email

Recent publications

Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial
Nature Medicine 2026cited by 2position: middledoi
Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis
Gut 2024cited by 17position: middledoi
Impact of <i>Helicobacter pylori</i> infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
Journal for ImmunoTherapy of Cancer 2023cited by 50position: middledoi
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial
The Lancet Oncology 2023cited by 44position: middledoi
Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
JNCI Journal of the National Cancer Institute 2023cited by 32position: middledoi
A Novel Microbiome Signature in Gastric Cancer
Annals of Surgery 2022cited by 50position: middledoi
A phase II study of siG12D-LODER in combination with chemotherapy in patients with locally advanced pancreatic cancer (PROTACT).
Journal of Clinical Oncology 2020cited by 48position: middledoi
A multimodality test to guide the management of patients with a pancreatic cyst
Science Translational Medicine 2019cited by 205position: middledoi
<i>EGFR</i> and <i>MET</i> Amplifications Determine Response to HER2 Inhibition in <i>ERBB2</i> -Amplified Esophagogastric Cancer
Cancer Discovery 2018cited by 145position: middledoi
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
Proceedings of the National Academy of Sciences 2017cited by 569position: middledoi
Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
Cancer Discovery 2017cited by 380position: middledoi
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype
Clinical Cancer Research 2017cited by 210position: middledoi
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
Gastroenterology 2015cited by 456position: middledoi
Pathologic Grade and Tumor Size are Associated with Recurrence-Free Survival in Patients with Duodenal Neuroendocrine Tumors
Journal of Gastrointestinal Surgery 2014cited by 73position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Steven B. Maron · Weill Cornell Medicine3 papers (2022–2023)Monika Laszkowska · Weill Cornell Medicine3 papers (2022–2023)Yelena Y. Janjigian · Cancer Clinic3 papers (2022–2023)Laura H. Tang · Colorado Permanente Medical Group3 papers (2014–2023)Daniel G. Coit · Weill Cornell Medicine2 papers (2022–2023)Vivian E. Strong · University of Colorado Denver2 papers (2022–2023) · 1 papers (2020–2020)William R. Jarnagin · Weill Cornell Medicine1 papers (2014–2014)David M. Faleck · Cornell University1 papers (2023–2023) · 1 papers (2020–2020)Eithan Galun · Hebrew University of Jerusalem1 papers (2020–2020)Ravit Geva · Tel Aviv University1 papers (2020–2020)Mithat Gönen · Centre de Recherche Épidémiologie et Statistique1 papers (2022–2022)Milind Javle · The University of Texas MD Anderson Cancer Center1 papers (2020–2020)Brian R. Untch · Memorial Sloan Kettering Cancer Center1 papers (2014–2014)Ping Gu · Memorial Sloan Kettering Cancer Center1 papers (2023–2023)David R. Jones · Concepts to Systems (United States)1 papers (2023–2023)Anna Maio · University of Campania "Luigi Vanvitelli"1 papers (2023–2023)Geoffrey Y. Ku · Cornell University1 papers (2023–2023)T. Peter Kingham · Weill Cornell Medicine1 papers (2014–2014)